The US Court of Appeals for the Federal Circuit affirmed a district court’s delisting of patents from the Orange Book because the patent claims ...
On December 20, 2024, the US Court of Appeals for the Federal Circuit released its opinion in Teva Branded Pharm. Prods. R&D, Inc. v. Amneal ...
The Ventolin HFA test MDIs also had an increased leak ... The manufacturers' reported dose per actuation for both MDIs is 108 µg of albuterol sulfate, which corresponds to 90 µg of albuterol ...
Amneal beats Teva’s challenge of ruling on some ProAir patents Decision could impact other ‘junk device listings,’ FTC says Five patents related to Teva Pharmaceutical Industries Ltd.’s ProAir HFA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback